|
Mar 27
|
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
|
|
Mar 27
|
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
|
Mar 22
|
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past three years
|
|
Mar 20
|
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
|
|
Mar 13
|
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
|
|
Mar 10
|
3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio
|
|
Mar 5
|
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
|
|
Jan 18
|
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
|
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Jan 14
|
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024
|
|
Jan 12
|
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
|
|
Jan 9
|
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
|
|
Jan 9
|
Catalyst (CPRX) is an Incredible Growth Stock: 3 Reasons Why
|
|
Jan 9
|
Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
|
|
Jan 5
|
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
|
|
Jan 4
|
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
|
|
Jan 3
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Dec 18
|
Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma
|
|
Dec 8
|
Why Is Catalyst (CPRX) Up 16.2% Since Last Earnings Report?
|
|
Dec 5
|
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
|